Z-ajoene induces apoptosis of HL-60 cells: Involvement of Bcl-2 cleavage

Nutrition and Cancer

Volumn 42, Issue 2, 2002, Pages 241-247

  Li, Min ^a   Min, Ji Mei ^a   Cui, Jing Rong ^a   Zhang, Li He ^a   Wang, Kui ^a   Valette, Annie ^b   Davrinche, Christian ^c   Wright, Michel ^d   Leung Tack, Jeanne ^d  

^a PEKING UNIVERSITY   (China)

^b Université de Toulouse Paul Sabatier   (France)

^c INSERM   (France)

^d INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AJOENE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL LOSS; CELL STRAIN HL 60; ENZYME ACTIVATION; GARLIC; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PROMOTER REGION; SPECIES DIFFERENTIATION; TARGET CELL; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; DISULFIDES; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; PHOSPHORYLATION; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2;

ALLIUM SATIVUM;

EID: 0036035982     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC422_14     Document Type: Article

References (36)

1. Han R: Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 12, 53-63, 1994.
2. You WC, Blot WJ, Chang YS, Ershow AG, Yang ZT, et al: Diet and high risk of stomach cancer in Shandong, China. Cancer Res 48, 3518-3523, 1988.
3. Agarwal KC: Therapeutic actions of garlic constituents. Med Res Rev 16, 111-124, 1996.
4. Milner JA: Garlic: Its anticarcinogenic and antitumorigenic properties. Nutr Rev 54, S82-S86, 1996.
5. Knowles LM and Milner JA: Allyl sulfides modify cell growth. In Drug Metabolism and Drug Interactions, Kingsley N (ed). Israel: Freund, 2000, pp 81-107.
6. Koch HP and Lawson LD: Garlic, 2nd Ed. Baltimore, MD: Williams & Wilkins, 1996, p 135.
7. Scharfenberg K, Ryll T, Wagner R, and Wagner KG: Injuries to cultivated BJA-B cells by ajoene, a garlic-derived natural compound: Cell viability, glutathione metabolism, and pools of acidic amino acids. J Cell Physiol 158, 55-60, 1994.
8. Scharfenberg K, Wagner R, and Wagner KG: The cytotoxic effect of ajoene, a natural product from garlic, investigated with different cell lines. Cancer Lett 53, 103-108, 1990.
9. Dirsch VM, Gerbes AL, and Vollmar AM: Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor κB. Mol Pharmacol 53, 402-407, 1998.
10. Zhang SQ, Zhao S, Min JM, Wang K, Liu SL, et al.: Z-ajoene induces apoptosis in tumor cell lines. Chin Bull Sci 43, 961-965, 1998.
11. Armstrong RC, Aja T, Xiang J, Gaur S, Krebs JF, et al.: Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 271, 16850-16855, 1996.
12. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347, 1994.
13. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, et al.: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43, 1995.
14. Reed JC: Bcl-2 family proteins. Oncogene 17, 3225-3236, 1998.
15. Carson DA and Ribeiro JM: Apoptosis and disease. Lancet 341, 1251-1254, 1993.
16. Pietenpol JA, Papadopoulos N, Markowitz S, Willson JK, Kinzler KW, et al.: Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res 54, 3714-3717, 1994.
17. Haldar S, Jena N, and Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92, 4507-4511, 1995.
18. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, et al.: Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 18, 3509-3517, 1998.
19. Sato T, Hanada, M, Bodrug S, Irie S, Iwama N, et al.: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91, 9238-9342, 1994.
20. Dimmeler S, Breitschopf K, Haendeler J, and Zeiher AM: Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway. J Exp Med 189, 1815-1822, 1999.
21. Chadebech P, Brichese L, Baldin V, Vidal S, and Valette A: Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage. Biochem Biophys Res Commun 262, 823-827, 1999.
22. Grandgirard D, Studer E, Mooney L, Belser T, Fellay I, et al.: α-viruses induce apoptosis in Bcl-2-overexpressing cells: Evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J 17, 1268-1278, 1998.
23. Li M, Cui JR, Ye Y, Min JM, Zhang LH, et al.: Antitumor activity of Z-ajoene, a natural compound from garlic: Antimitotic and microtubule-interaction properties. Carcinogenesis 23, 573-579, 2002.
24. Lu MS, Min JM, and Wang K: Studies on the organosulfur compounds of garlic. Chin Tradition Herb Drug 32, 867-870.
25. Rodriguez J and Deinhardt F: Preparation of a semipermanent mounting medium for fluorescence antibody study. Virology 12, 316-317, 1960.
26. Canitrot Y, Frit P, and Salles B: Deficient apoptotic process in cisplatin-resistant L1210 cells cannot account for the cellular response to various drug treatments. Biochem Biophys Res Commun 234, 573-577, 1997.
27. Vermes I, Haanen C, Steffens-Nakken H, and Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184, 39-51, 1995.
28. Alam A, Braun MY, Hartgers F, Lesage S, Cohen L, et al.: Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus. J Exp Med 186, 1503-1512, 1997.
29. Fujita N and Tsurao T: Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem Biophys Res Commun 246, 484-488, 1998.
30. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, et al.: Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 274, 21155-21161, 1999.
31. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, et al.: Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966-1968, 1997.
32. Tomicic MT and Kaina B: Hamster Bcl-2 protein is cleaved in vitro and in cells by caspase-9 and caspase-3. Biochem Biophys Res Commun 281, 404-408, 2001.
33. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, et al.: Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271, 4573-4576, 1996.
34. Blagosklonny MV, Giannakakou P, el-Deiry WS, Kingston DG, Higgs PI, et al.: Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death. Cancer Res 57, 130-135, 1997.
35. Grimm S, Bauer MK, Baeuerle PA, and Schulze-Osthoff K: Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol 134, 13-23, 1996.
36. Huang Z: Bcl-2 family proteins as targets for anticancer drug design. Oncogene 19, 6627-6631, 2000.